A placebo-controlled study on urokinase therapy in systemic sclerosis
- 31 December 1996
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 50 (8) , 363-368
- https://doi.org/10.1016/s0753-3322(96)89669-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Upregulation of urokinase receptor expression on migrating endothelial cellsThe Journal of cell biology, 1993
- Cyclosporine in systemic sclerosis. results of a forty‐eight–week open safety study in ten patientsArthritis & Rheumatism, 1993
- Treatment of systemic sclerosisCurrent Opinion in Rheumatology, 1991
- Treatment of systemic sclerosis.Annals of the Rheumatic Diseases, 1991
- 5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.Annals of the Rheumatic Diseases, 1990
- Cutaneous Sclerosis, Aplastic Anemia, and Antithymocyte GlobulinAnnals of Internal Medicine, 1989
- Plasma exchange in the treatment of progressive systemic sclerosisPlasma Therapy and Transfusion Technology, 1987
- Progressive systemic sclerosis and S-adenosylmethionineClinical Rheumatology, 1985
- Plasmapheresis and immunosuppressive drug therapy in sclerodermaArthritis & Rheumatism, 1981
- Skin thickness and collagen content in progressive systemic sclerosis and localized sclerodermaArthritis & Rheumatism, 1979